I found this article today. I certainly hope that nothing will ever cause them to stop selling it. It has been my salvation. WASHINGTON (Reuters) - Eli Lilly and Co. has expanded its warning about possible liver-related problems with its depression drug, Cymbalta, and cautioned doctors against its use in chronic liver disease patients, U.S. health regulators said on Monday. A new label for the antidepressant, known generically as duloxetine, also includes reports of hepatitis, jaundice and other liver-related problems in patients using the drug, the U.S. Food and Drug Administration said on its Web site. "Some of these reports indicate that patients with preexisting liver disease who take duloxetine may have an increased risk for further liver damage," the company said in letter to doctors dated October 5. Cymbalta, which is also approved to treat a type of nerve damage caused by diabetes, has been known to cause liver problems. The label earlier warned against using the drug with alcohol. "Cymbalta should ordinarily not be prescribed to patients with substantial alcohol use or evidence of chronic liver disease," according to the new label, which was also posted online. The letter and new label are posted online at http://www.fda.gov/medwatch/safety/2005/safety05.htm#Cymbalta.